Here is some additional information for those wanting to know more about the Maternit21 test:
(oops, won't let me post the link...sorry everyone -- you can just do a google search for sequenomcmm though and it will lead to the website with all the info you need)
Something I found interesting: "Recent published data indicate that the core technology which underlies the MaterniT21 test also has the capability to detect other aneuploidies, such as trisomy 18 and trisomy 13. If either of these aneuploidies is detected by the MaterniT21 test, Sequenom CMM will be reporting these results to the physician. The performance of the test for trisomy 18 and trisomy 13 has not been validated in a large clinical study. A negative result does not preclude the presence of trisomy 18 or trisomy 13."
So the test may catch T18 or T13 as well, but they just couldn't obtain statistical significance in their studies (probably because there are far fewer instances of these abnormalities in the general population than T21 and it would take years to come up with enough samples to get a statistically significant results).
Also, the test was only available in these markets at launch in October: Seattle, San Francisco, Los Angeles, San Diego, Phoenix, Denver/Salt Lake City, St. Louis, Dallas, Houston, Chicago, Indianapolis, Detroit, Pittsburgh, Nashville, Atlanta, Orlando, Charlotte, Baltimore, Philadelphia, and Boston.
I can't find whether or not new markets have been added since...it seems the launch date was October. Still, I think a good doctor should be aware of this test given that it is non-invasive and doesn't harm the fetus.